Last reviewed · How we verify

NCT06284200

Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis

Status unknown Last updated 28 February 2024
What this trial tests

trial in Sarcopenia in 48 participants. Status unknown.

Timeline
23 June 2023
Primary endpoint
23 March 2024
23 June 2024

Quick facts

Lead sponsorKayseri City Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment48
Start date23 June 2023
Primary completion23 March 2024
Estimated completion23 June 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Kayseri City Hospital

Who can join

18 and older, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

introduction: In this study, the presence of sarcopenia in cases with early rheumatoid arthritis and established rheumatoid arthritis will be compared. Materials and Method: According to the power analysis, 24 patients with early rheumatoid arthritis and 24 patients with established rheumatoid arthritis who meet the 2010 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) rheumatoid arthritis (RA) classification criteria will be included in the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Kayseri City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06284200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing